Two different STAT1 gain-of-function mutations lead to diverse IFN-γ-mediated gene expression

被引:13
|
作者
Ovadia, Adi [1 ,2 ,3 ,4 ]
Sharfe, Nigel [1 ,2 ,3 ,4 ]
Hawkins, Cynthia [5 ]
Laughlin, Suzanne [6 ]
Roifman, Chaim M. [1 ,2 ,3 ,4 ]
机构
[1] Hosp Sick Children, Dept Paediat, Div Immunol & Allergy, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Hosp Sick Children, Canadian Ctr Primary Immunodeficiency, Toronto, ON, Canada
[4] Hosp Sick Children, Jeffrey Modell Res Lab Diag Primary Immunodeficie, Toronto, ON, Canada
[5] Hosp Sick Children, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[6] Hosp Sick Children, Dept Radiol, Toronto, ON, Canada
来源
NPJ GENOMIC MEDICINE | 2018年 / 3卷
关键词
UNDERLIE;
D O I
10.1038/s41525-018-0063-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Signal transducer and activator of transcription 1 (STAT1) regulates multiple biological processes downstream of a variety of cytokine receptors in many cell types. Heterozygous gain-of-function (GOF) mutations in STAT1 have been associated with a diverse phenotype encompassing chronic mucocutaneous candidiasis (CMCC) and declining immunity. There is no dear correlation between STAT1 domain-specific mutations and phenotype, and it remains unclear why GOF mutations in STAT1 result in such a wide spectrum of clinical presentations. To begin exploring this dilemma, we have studied the patterns of gene expression mediated by two different GOF mutations. Analysis of IFN-gamma response elements using RNA microarrays in cells transfected with the rare H629Y mutant or the common R274G mutant showed distinct patterns of gene expression. We show here that the impact of GOF mutations in STAT1 is variant-specific. This difference in gene expression may explain the diversity in clinical manifestations experienced by these patients.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Myocarditis in a congenital STAT1 gain-of-function patient
    Roosens, Willem
    Staels, Frederik
    Herrero, Cecilia Iglesias
    Gijsbergs, Rik
    Moens, Leen
    Bossuyt, Xavier
    Bogaert, Jan
    Meyts, Isabelle
    Van Aelst, Lucas
    Schrijvers, Rik
    CLINICAL IMMUNOLOGY, 2023, 250 : 31 - 32
  • [22] Orf Infection in a Patient with Stat1 Gain-of-Function
    Sara Sebnem Kilic
    Anne Puel
    Jean-Laurent Casanova
    Journal of Clinical Immunology, 2015, 35 : 80 - 83
  • [23] GAIN-OF-FUNCTION MUTATIONS IN STAT1 UNDERLIE AUTOSOMAL DOMINANT CHRONIC MUCOCUTANEOUS CANDIDIASIS
    Okada, S.
    Kong, X-F.
    Cypowyj, S.
    Kreins, A.
    Liu, L.
    Abel, L.
    Picard, C.
    Boisson-Dupuis, S.
    Puel, A.
    Casanova, J-L.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 92 - 93
  • [24] Inborn errors of immunity with loss- and gain-of-function germline mutations in STAT1
    Asano, Takaki
    Utsumi, Takanori
    Kagawa, Reiko
    Karakawa, Shuhei
    Okada, Satoshi
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2023, 212 (02): : 96 - 106
  • [25] Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype
    Toubiana, Julie
    Okada, Satoshi
    Hiller, Julia
    Oleastro, Matias
    Lagos Gomez, Macarena
    Aldave Becerra, Juan Carlos
    Ouachee-Chardin, Marie
    Fouyssac, Fanny
    Girisha, Katta Mohan
    Etzioni, Amos
    Van Montfrans, Joris
    Camcioglu, Yildiz
    Kerns, Leigh Ann
    Belohradsky, Bernd
    Blanche, Stephane
    Bousfiha, Aziz
    Rodriguez-Gallego, Carlos
    Meyts, Isabelle
    Kisand, Kai
    Reichenbach, Janine
    Renner, Ellen D.
    Rosenzweig, Sergio
    Grimbacher, Bodo
    van de Veerdonk, Frank L.
    Traidl-Hoffmann, Claudia
    Picard, Capucine
    Marodi, Laszlo
    Morio, Tomohiro
    Kobayashi, Masao
    Lilic, Desa
    Milner, Joshua D.
    Holland, Steven
    Casanova, Jean-Laurent
    Puel, Anne
    Cypowyj, Sophie
    Thumerelle, Caroline
    Toulon, Antoine
    Bustamante, Jacinta
    Tahuil, Natalia
    Salhi, Aicha
    Boiu, Sorina
    Chopra, Charu
    Di Giovanni, Daniela
    Bezrodnik, Liliana
    Boutros, Jeannette
    Thomas, Caroline
    Lacuesta, Gina
    Jannier, Sarah
    Korganow, Anne-Sophie
    Paillard, Catherine
    BLOOD, 2016, 127 (25) : 3154 - 3164
  • [26] STAT1 gain-of-function heterozygous cell models reveal diverse interferon-signature gene transcriptional responses
    Scott, Ori
    Lindsay, Kyle
    Erwood, Steven
    Mollica, Antonio
    Roifman, Chaim M.
    Cohn, Ronald D.
    Ivakine, Evgueni A.
    NPJ GENOMIC MEDICINE, 2021, 6 (01)
  • [27] STAT1 gain-of-function heterozygous cell models reveal diverse interferon-signature gene transcriptional responses
    Ori Scott
    Kyle Lindsay
    Steven Erwood
    Antonio Mollica
    Chaim M. Roifman
    Ronald D. Cohn
    Evgueni A. Ivakine
    npj Genomic Medicine, 6
  • [28] Rosacea and demodicidosis associated with gain-of-function mutation in STAT1
    Second, J.
    Korganow, A. -S.
    Jannier, S.
    Puel, A.
    Lipsker, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (12) : E542 - E544
  • [29] Functional analysis of two STAT1 gain-of-function mutations in two Iranian families with autosomal dominant chronic mucocutaneous candidiasis
    Ostadi, Vajiheh
    Sherkat, Roya
    Migaud, Melanie
    Modaressadeghi, Seyed-Mehran
    Casanova, Jean-Laurent
    Puel, Anne
    Nekooie-Marnany, Nioosha
    Ganjalikhani-Hakemi, Mazdak
    MEDICAL MYCOLOGY, 2021, 59 (02) : 180 - 188
  • [30] STAT1 Gain-of-Function Mutation in Chronic Mucocutaneous Candidiasis
    Antoniadi, Marita
    Tzanoudaki, Marianna
    Karkanis, Vaggelis
    Kostaridou, Stavroula
    Tsagris, Vasileios
    INDIAN JOURNAL OF PEDIATRICS, 2024, 91 (12): : 1312 - 1312